Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks

Novo Nordisk’s obesity medicine Wegovy reduces the risk of heart attacks and strokes according to a highly anticipated study. People with obesity or are overweight with a history of heart …

Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks Read More

AstraZeneca joins hand with Vietnamese Ministry of Health for sustainable collaborations

Sweden’s AstraZeneca recently signed the Memorandum of Understanding (MoU) with the Vietnamese Ministry of Health to enhance healthcare and expand sustainable development collaborations in Vietnam. “In the next five years …

AstraZeneca joins hand with Vietnamese Ministry of Health for sustainable collaborations Read More